These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25796579)

  • 1. Effect of Immunosuppressive Therapies for the Treatment of Inflammatory Bowel Disease on Response to Routine Vaccinations: A Meta-Analysis.
    Nguyen DL; Nguyen ET; Bechtold ML
    Dig Dis Sci; 2015 Aug; 60(8):2446-53. PubMed ID: 25796579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccinations in immunosuppressive-dependent pediatric inflammatory bowel disease.
    Nguyen HT; Minar P; Jackson K; Fulkerson PC
    World J Gastroenterol; 2017 Nov; 23(42):7644-7652. PubMed ID: 29204064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological response to the 2009 H1N1 influenza vaccination in patients with inflammatory bowel disease.
    Cullen G; Bader C; Korzenik JR; Sands BE
    Gut; 2012 Mar; 61(3):385-91. PubMed ID: 21757451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppression impairs response to pneumococcal polysaccharide vaccination in patients with inflammatory bowel disease.
    Melmed GY; Agarwal N; Frenck RW; Ippoliti AF; Ibanez P; Papadakis KA; Simpson P; Barolet-Garcia C; Ward J; Targan SR; Vasiliauskas EA
    Am J Gastroenterol; 2010 Jan; 105(1):148-54. PubMed ID: 19755964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Booster influenza vaccination does not improve immune response in adult inflammatory bowel disease patients treated with immunosuppressives: a randomized controlled trial.
    Matsumoto H; Ohfuji S; Watanabe K; Yamagami H; Fukushima W; Maeda K; Kamata N; Sogawa M; Shiba M; Tanigawa T; Tominaga K; Watanabe T; Fujiwara Y; Hirota Y; Arakawa T
    J Gastroenterol; 2015 Aug; 50(8):876-86. PubMed ID: 25672513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of immunosuppressive therapy on hepatitis B vaccination in inflammatory bowel diseases.
    Belle A; Baumann C; Bigard MA; Zallot C; Gizard E; Guéant JL; Bronowicki JP; Peyrin-Biroulet L
    Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):877-81. PubMed ID: 26121376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and Safety of Influenza Vaccine in Inflammatory Bowel Disease Patients Treated or not with Immunomodulators and/or Biologics: A Two-year Prospective Study.
    Launay O; Abitbol V; Krivine A; Slama LB; Bourreille A; Dupas JL; Hébuterne X; Savoye G; Deplanque D; Bouhnik Y; Pelletier AL; Galtier F; Laharie D; Nachury M; Zerbib F; Allez M; Bommelaer G; Duclos B; Lucht F; Gougeon ML; Tartour E; Rozenberg F; Hanslik T; Beaugerie L; Carrat F;
    J Crohns Colitis; 2015 Dec; 9(12):1096-107. PubMed ID: 26351392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response to influenza and pneumococcal vaccines in adults with inflammatory bowel disease: A systematic review and meta-analysis of 1429 patients.
    Müller KE; Dohos D; Sipos Z; Kiss S; Dembrovszky F; Kovács N; Solymár M; Erőss B; Hegyi P; Sarlós P
    Vaccine; 2022 Mar; 40(13):2076-2086. PubMed ID: 35227523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody and cell-mediated immune response to whole virion and split virion influenza vaccine in patients with inflammatory bowel disease on maintenance immunosuppressive and biological therapy.
    Bálint A; Farkas K; Éva PK; Terhes G; Urbán E; Szucs M; Nyári T; Bata Z; Nagy F; Szepes Z; Miheller P; Lorinczy K; Lakatos PL; Lovász B; Tamás S; Kulcsár A; Berényi A; Törocsik D; Daróczi T; Saródi Z; Wittmann T; Molnár T
    Scand J Gastroenterol; 2015 Feb; 50(2):174-81. PubMed ID: 25384624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of surveillance of hepatitis b and hepatitis c in patients with inflammatory bowel disease under anti-TNF therapies: multicenter prospective observational study (REPENTINA 3).
    Loras C; Gisbert JP; Saro MC; Piqueras M; Sánchez-Montes C; Barrio J; Ordás I; Montserrat A; Ferreiro R; Zabana Y; Chaparro M; Fernández-Bañares F; Esteve M;
    J Crohns Colitis; 2014 Nov; 8(11):1529-38. PubMed ID: 25052345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 1: Live Vaccines.
    Benchimol EI; Tse F; Carroll MW; deBruyn JC; McNeil SA; Pham-Huy A; Seow CH; Barrett LL; Bessissow T; Carman N; Melmed GY; Vanderkooi OG; Marshall JK; Jones JL
    Gastroenterology; 2021 Aug; 161(2):669-680.e0. PubMed ID: 33617891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pANCA positivity predicts lower clinical response to infliximab therapy among patients with IBD.
    Nguyen DL; Nguyen ET; Bechtold ML
    South Med J; 2015 Mar; 108(3):139-43. PubMed ID: 25772045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease.
    Mamula P; Markowitz JE; Piccoli DA; Klimov A; Cohen L; Baldassano RN
    Clin Gastroenterol Hepatol; 2007 Jul; 5(7):851-6. PubMed ID: 17544875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Efficacy of Biologic Agents for the Management of Inflammatory Bowel Disease After Liver Transplantation.
    Shaikh SA; Fitzgerald L; Tischer S
    Pharmacotherapy; 2017 Dec; 37(12):1578-1585. PubMed ID: 28960437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infliximab and/or immunomodulators inhibit immune responses to trivalent influenza vaccination in adults with inflammatory bowel disease.
    Hagihara Y; Ohfuji S; Watanabe K; Yamagami H; Fukushima W; Maeda K; Kamata N; Sogawa M; Shiba M; Tanigawa T; Tominaga K; Watanabe T; Fujiwara Y; Hirota Y; Arakawa T
    J Crohns Colitis; 2014 Mar; 8(3):223-33. PubMed ID: 24011513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effectiveness of two protocols for vaccination (standard and double dosage) against hepatitis B virus in patients with inflammatory bowel disease.
    Gisbert JP; Menchén L; García-Sánchez V; Marín I; Villagrasa JR; Chaparro M
    Aliment Pharmacol Ther; 2012 Jun; 35(12):1379-85. PubMed ID: 22530631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination strategies in pediatric inflammatory bowel disease.
    Dipasquale V; Romano C
    Vaccine; 2017 Oct; 35(45):6070-6075. PubMed ID: 28967524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of the vaccination in inflammatory bowel disease.
    Carrera E; Manzano R; Garrido E
    World J Gastroenterol; 2013 Mar; 19(9):1349-53. PubMed ID: 23538553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to a predefined vaccination program in patients with inflammatory bowel disease.
    Ruiz-Cuesta P; González-Alayón C; Jurado-García J; Iglesias-Flores EM; Barranco-Quintana JL; García-García L; Salgueiro-Rodríguez IM; Benitez-Cantero JM; García-Sánchez V
    Gastroenterol Hepatol; 2016; 39(6):385-92. PubMed ID: 26601992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced therapy for inflammatory bowel disease: a guide for the primary care physician.
    Thomas A; Lodhia N
    J Am Board Fam Med; 2014; 27(3):411-20. PubMed ID: 24808120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.